Fund shareholders of Corvus Pharmaceuticals Inc
ISIN US2210151005 · United States · LEI 549300I3AVJ8F75NCX65
- Fund shareholders
- 167
- Of which ETFs
- 29 138 other funds
- Value held
- 255.9M $ 31.6M SEK
- Share of capital
- 20.4 % of 84.1M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,339,506 | 34.2M $ | 0.00 % | 2.78 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2,116,858 | 31M $ | 0.42 % | 2.52 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,567,922 | 22.9M $ | 0.03 % | 1.86 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 820,462 | 12M $ | 0.01 % | 0.98 % | as of Mar 31, 2026 ↗ |
| Hood River Small-Cap Growth Fund Manager Directed Portfolios | 744,094 | 10.9M $ | 0.21 % | 0.88 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 725,099 | 10.6M $ | 0.10 % | 0.86 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 722,282 | 10.6M $ | 0.08 % | 0.86 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 637,084 | 9.7M $ | 0.03 % | 0.76 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 567,600 | 8.3M $ | 0.10 % | 0.67 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 550,000 | 8M $ | 0.51 % | 0.65 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 525,679 | 7.7M $ | 0.06 % | 0.62 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 473,326 | 6.9M $ | 0.09 % | 0.56 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 379,475 | 6.9M $ | 0.02 % | 0.45 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 283,618 | 5.2M $ | 0.03 % | 0.34 % | as of Feb 28, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 226,837 | 31.6M SEK | 0.20 % | 0.27 % | as of Mar 31, 2026 ↗ |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 188,583 | 2.9M $ | 0.20 % | 0.22 % | as of Apr 30, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 174,676 | 2.7M $ | 0.11 % | 0.21 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 167,790 | 3.1M $ | 0.02 % | 0.20 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 162,216 | 2.4M $ | 0.20 % | 0.19 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 147,435 | 2.2M $ | 0.34 % | 0.18 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 141,399 | 2.1M $ | 0.03 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 135,399 | 2.5M $ | 0.00 % | 0.16 % | as of Feb 28, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 122,721 | 2.2M $ | 0.16 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 121,201 | 1.8M $ | 0.35 % | 0.14 % | as of Apr 30, 2026 ↗ |
| VictoryShares US Small Mid Cap Value Momentum ETF Victory Portfolios II | 121,155 | 1.8M $ | 0.13 % | 0.14 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 110,424 | 2M $ | 0.03 % | 0.13 % | as of Feb 27, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 107,758 | 2M $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 105,776 | 1.5M $ | 0.00 % | 0.13 % | as of Mar 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 102,168 | 1.6M $ | 0.97 % | 0.12 % | as of Apr 30, 2026 ↗ |
| HARTFORD SMALL COMPANY HLS FUND HARTFORD SERIES FUND INC | 95,250 | 1.4M $ | 0.36 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 95,146 | 1.4M $ | 0.03 % | 0.11 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 91,355 | 1.7M $ | 0.04 % | 0.11 % | as of Feb 27, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 82,148 | 1.5M $ | 0.94 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 77,000 | 1.2M $ | 0.03 % | 0.09 % | as of Apr 30, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 68,100 | 996.3K $ | 0.09 % | 0.08 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 66,905 | 978.8K $ | 0.03 % | 0.08 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 66,564 | 1.2M $ | 0.88 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 62,933 | 956K $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Hood River New Opportunities Fund Manager Directed Portfolios | 62,321 | 911.8K $ | 0.14 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 61,215 | 895.6K $ | 0.36 % | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 53,757 | 786.5K $ | 0.05 % | 0.06 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 52,479 | 958.3K $ | 1.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 52,412 | 957K $ | 0.07 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 48,925 | 715.8K $ | 0.06 % | 0.06 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 48,764 | 713.4K $ | 0.11 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 47,656 | 870.2K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 46,695 | 709.3K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF Goldman Sachs ETF Trust | 45,480 | 830.5K $ | 0.09 % | 0.05 % | as of Feb 28, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 42,768 | 625.7K $ | 0.07 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 40,700 | 595.4K $ | 0.09 % | 0.05 % | as of Mar 31, 2026 ↗ |
| MassMutual Small Cap Growth Equity Fund MASSMUTUAL SELECT FUNDS | 39,530 | 578.3K $ | 0.10 % | 0.05 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 39,400 | 576.4K $ | 0.03 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 38,347 | 561K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 37,880 | 575.4K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 37,511 | 569.8K $ | 0.31 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 35,779 | 523.4K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 34,590 | 506.1K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 33,332 | 506.3K $ | 0.07 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 32,976 | 500.9K $ | 1.34 % | 0.04 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 31,697 | 463.7K $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Wellington Small Cap Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 31,104 | 455.1K $ | 0.13 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 30,015 | 439.1K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 29,306 | 535.1K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 28,060 | 410.5K $ | 0.20 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 27,905 | 423.9K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 25,974 | 394.5K $ | 0.02 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Brighthouse/Wellington Large Cap Research Portfolio Brighthouse Funds Trust I | 25,232 | 369.1K $ | 0.02 % | 0.03 % | as of Mar 31, 2026 ↗ |
| The Hartford Small Cap Growth Fund HARTFORD MUTUAL FUNDS II, INC | 25,123 | 381.6K $ | 0.13 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 24,483 | 371.9K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 24,076 | 365.7K $ | 0.13 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 23,189 | 339.3K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 22,672 | 414K $ | 0.03 % | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 22,321 | 326.6K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 21,900 | 320.4K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 21,800 | 318.9K $ | 0.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 20,242 | 296.1K $ | 0.43 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 20,000 | 292.6K $ | 0.24 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 19,845 | 290.3K $ | 0.13 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 19,710 | 288.4K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 18,880 | 276.2K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 18,473 | 270.3K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 16,788 | 245.6K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| MML Small Cap Growth Equity Fund MML SERIES INVESTMENT FUND | 16,550 | 242.1K $ | 0.18 % | 0.02 % | as of Mar 31, 2026 ↗ |
| HARTFORD SMALL CAP GROWTH HLS FUND HARTFORD SERIES FUND INC | 15,700 | 229.7K $ | 0.04 % | 0.02 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Index Fund Nationwide Variable Insurance Trust | 12,692 | 185.7K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 12,357 | 180.8K $ | 0.11 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 12,240 | 179.1K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 12,117 | 177.3K $ | 0.18 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 11,842 | 216.2K $ | 0.08 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Small Cap Index Trust John Hancock Variable Insurance Trust | 11,680 | 170.9K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 11,573 | 169.3K $ | 0.41 % | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 11,549 | 169K $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 11,105 | 168.7K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 10,787 | 163.9K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust | 9,998 | 146.3K $ | 0.08 % | 0.01 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 9,404 | 137.6K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 9,125 | 138.6K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| DWS Small Cap Index VIP DEUTSCHE DWS INVESTMENTS VIT FUNDS | 8,998 | 131.6K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT GS Small Cap Equity Insights Fund Nationwide Variable Insurance Trust | 8,972 | 131.3K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 8,703 | 127.3K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.34 % | as of Apr 30, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 1.00 % | as of Feb 28, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 0.97 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 0.94 % | as of Feb 28, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.88 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.51 % | as of Mar 31, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 0.43 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.42 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.41 % | as of Mar 31, 2026 ↗ |
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 0.36 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 166 | +53 | 16,958,315 | +61.8 % |
| 2026Q1 | 113 | +19 | 10,482,536 | +31.4 % |
| 2025Q4 | 94 | +18 | 7,975,440 | +12.2 % |
| 2025Q3 | 76 | +43 | 7,108,338 | +91.4 % |
| 2025Q2 | 33 | +7 | 3,713,407 | +4.3 % |
| 2025Q1 | 26 | +8 | 3,560,130 | +13.0 % |
| 2024Q4 | 18 | 0 | 3,150,428 | +42.7 % |
| 2024Q3 | 18 | +1 | 2,207,894 | +2.8 % |
| 2024Q2 | 17 | -1 | 2,147,688 | +11.3 % |
| 2024Q1 | 18 | -1 | 1,930,013 | +1.0 % |
| 2023Q4 | 19 | 1,910,735 |
Institutional managers
160 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 7,165,006 | 104.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 6,160,422 | 90.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,565,992 | 52.2M $ | as of Mar 31, 2026 |
| ADAMS STREET PARTNERS LLC | 3,275,616 | 47.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,917,300 | 42.7K $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 2,805,816 | 41M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,498,825 | 36.6M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 2,491,539 | 36.5M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,318,517 | 33.9M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 2,292,441 | 33.5M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 2,258,735 | 33M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 1,831,233 | 26.8M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,752,798 | 25.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,712,741 | 25.1M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,674,875 | 24.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,540,809 | 22.5M $ | as of Mar 31, 2026 |
| Hood River Capital Management LLC | 1,335,109 | 19.5M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 1,100,000 | 16.1M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,070,174 | 15.7M $ | as of Mar 31, 2026 |
| Catalio Capital Management, LP | 891,933 | 13M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 866,362 | 12.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | 11M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 686,216 | 10M $ | as of Mar 31, 2026 |
| DCF Advisers, LLC | 637,500 | 9.3M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 550,000 | 8M $ | as of Mar 31, 2026 |
Declared shareholders of Corvus Pharmaceuticals Inc
3 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sirenia Capital Management LP and 1 other | 7.50 % | 6,831,828 | as of Mar 31, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 6.40 % | 5,387,818 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Corvus Pharmaceuticals Inc". https://titelia.com/en/stocks/corvus-pharmaceuticals-inc-US2210151005